This study was performd on 50 serum specimens of patients with type 2 diabetes, in addition, 50 normal specimens were investigated as control group. The activity rate of LAP in patients (560.46 10.504) I.U/L and activity rate of LAP in healthy(10.58 4.39)I.U/L.The results of the study reveal that Leucine aminopeptidase (LAP) activity of type 2 diabetes patient s serum shows a high signifiacant increase (p < 0.001) compare to healthy subjects. Addition preparation leucine amide as substrate of LAP, identification melting point and spectra by FTIR.
Introduction
Diabetes mellitus (sugar diabetes) is the most common illness due to hormonal imbalance. Symptoms include: sugar in the urine; frequent,copious urination;abnormal thirst, polyphagia which is excessive eating rapid weight loss, general weakness, drowsiness and fatigue, itching of the genitals and skin, visual disturbances and blurring and skin disorders,such as boils carbuncles,and infection. [1] . The ability of B-cesells to adopt to insulin resistance depends on various genetic factors that determine the total B-cell mass, rates of replication and apoptosis of the cells, and the activity of key biochemical components of cells.Environmental factors can probably aggravate the genetic predisposition leading to B-cell failure [2] . Leucine aminopeptidase (LAP) (a-amino acylpeptide hydrolases cytosol, E.C. 3. 4. 11.1) is aproteolytic enzyme which hydrolyses the peptide bond adjacent to afree group.it is called leucine aminopeptidase because it rapidly catalyzes the hydrolysis of leucine containing amino peptidase, however, it also catalyzes the hydrolytic release of other amino acids located at the N-terminal end of various proteins. [3] [4] [5] [6] . It has amolecular weight 326,000 [7] . LAP was detected in human tissues, animals, plants and bacteria [8] [9] [10] . High activities are seen in the small intestinal mucosa, pancreas [8] , stromal cells of the uters, and hepato cyets [3] [4] [5] [6] [7] [8] [9] [10] [11] .
Determination of microsomal leucine aminopeptidase activity in serum is of clinical significance, since LAP levels are elevated in obstructive jaundice, liver cirrhosis, liver carcinoma and also during the late part of pregnancy [12] . The serum LAP level may be apotential activity indicator for systemic lupus erthematosus [13] .
L-leucinamide, a more specific substrate was synthesized [14] . Leucinamide was preferable substrate for the measurement of activities of serum LAP in the clinical examination [15] .
The aim of study preparation and purification substrate (Leucinamide) of enzyme LAP , in addition measurement activity of LAP in patient s serum with type 2 Diabetes.
Material and Methods Preparation of leucine amide: 1-Preparation of ester leucine amide
Ester leucine amide was prepared by dissolved (0.1) mole of leucine as amino acid in absolute ethanol (50-100)ml , added (5ml) of concentration sulfonic acid gradually with stirring and then reflex for (5-6hr) (during reflexing added 5 ml Toluene).Continued reflex for (2hr) and distillation for (30min).Added (6-7ml) of ethanol and repeated the reflex with adding (3ml) Toluene.
After completed reaction and freezed mixture, equilibrated acid by usded NaHCO3 (Satureted solution). When prcipeted substance or separated by funnal concentred, dried and measured melting point. Then added bicarbonate to filterate [16] .
2-Preparation of Amide from esters:
Added(0.1mole) of ester leucine (prepared in step 1) to (25ml) of conc.ammonium solution in conical flask it s capucity (100ml) . Closed the vent of flask and then continued stirring within (10-15min) .Left the mixture to stable for (24hr), filtred crystal of amide and washed in the fewer amount of coled distled water(0-5) C. Recrystillization using by hot distled water and dried by air or hot oven. Then measured melting point [16] .
Specimen:
Fifty serum samples obtained from normals (20) men and (30) women, age (40-70) years, and (50) patient s serum with type 2 diabetes (25 men and 25 women), age (42-75) years. From each patients a detailed history was taken concerning the illness, (age at which the patient consults his physician), complication of the disease other associated diseases residency and their jobs or whether taking any drugs, and smoking. The patients were diagnosed by specialist doctars in Al-Yarmok hospital (Diabetic center).
Measurement activity of LAP in serum:
The measurement method is based on the described by Binkley and Torres (1960) [17] . The rate of decrease in absobance at (238nm) resulting from the hydrolysis of L-leucine amide is proportional to the catalytic activity of the enzyme. Determination activity of LAP by compared absorbance of sample with standard curve for different concentration of ammonia.
Result and Discussion
Leucinamide was obtained (m.p 250 C), the formation of Leucinamide is characterized by using in Fourier Transformation (FTIR) spectrum which showed, strong bonds for C=O and NH2 of the amide , at 1678 cm -1 and 3313-3194 cm -1 combired with the disappearance of v OH for the leucine Fig.(1), (2) . [18] , [19] . Results this study illustrate difference in levels of LAP activity in (50) patients serum with type 2 diabetes with (50) normals as shown Fig. (3) and the results, as shown in Fig.(4) refers to LAP activity in serum of normal and patients with type 2 diabetes (male) was slightly higher than that of femal serum of normal and patients with type 2 diabetes [14] . These results suggest that LAP has sensitivity and diagnostic significance .Elevated LAP activity in serum usually indicates diseases of liver, pancreas and bile ducts and elevation is less affected by damage of liver parenchyma than by active participation of biliary tract in the process [8] [20] . Further studies may indicate that some or all of these increases in leucine amino peptidase activity are under endocrine control [14] . I.U/L, significant increase (p<0.001) [21] . These results also suggested by the higher levels of LAP activity in patients and normal (male) than in patients and normal (femal) [14] .
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